Clinical Trials Directory

Trials / Completed

CompletedNCT00778011

Uncomplicated Nausea and Vomiting in the Emergency Department

Ondansetron 4 mg vs. 2 mg vs. Metoclopramide 10 mg for Nausea and Vomiting in the Emergency Department: A Randomized, Double-Blind Clinical Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
137 (actual)
Sponsor
WellSpan Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Nausea and vomiting is a common complaint in the emergency department. Treatment is important for many reasons. In addition to patient comfort, there are adverse effects secondary to vomiting such as dehydration, metabolic alkalosis, Mallory-Weiss tears, and aspiration. Two mediations common used for nausea in ED patients include Ondanesetron and Metoclopramide.

Detailed description

This study will compare Ondansetron 4 mg vs 2 mg vs Metoclopramide 10 mg to look for efficacy in nausea and vomiting treatment for patients in the ED with many different causes. We will also look for cost effectiveness as well, since Metoclopramide is much less expensive than Ondansetron, which is less expensive at lower doses. There is little research about nausea medication in the ED literature even though these medications are used frequently in the ED for many causes of nausea.

Conditions

Interventions

TypeNameDescription
DRUGOndansetrondosage
DRUGOndansetron4 mg
DRUGMetoclopramide10 mg IV

Timeline

Start date
2005-11-01
Primary completion
2006-12-01
Completion
2006-12-01
First posted
2008-10-23
Last updated
2012-06-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00778011. Inclusion in this directory is not an endorsement.